PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Leader Biomedical

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Leader Biomedical Launches Comprehensive Orthobiologics Portfolio - Leader Biomedical has launched the OssGro® range of synthetic grafts to complement its existing eTiss® line of human allografts used for spine, trauma, and orthopaedic indications.The company will also enter the sports medicine market with the X-grip
Leader Biomedical Launches Comprehensive Orthobiologics Portfolio

 

NewswireToday - /newswire/ - Amsterdam, North Holland, Netherlands, 2016/02/23 - Leader Biomedical has launched the OssGro® range of synthetic grafts to complement its existing eTiss® line of human allografts used for spine, trauma, and orthopaedic indications.The company will also enter the sports medicine market with the X-grip.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

To better meet the need for biocompatible grafts with good osteoconductive properties, Leader Biomedical has launched the OssGro® range of synthetic grafts to complement its existing eTiss® line of human allografts used for spine, trauma, and orthopaedic indications.The company will also enter the sports medicine market with the X-grip® anterior cruciate ligament (ACL)reconstruction system.

OssGro® relies on the proven combination of hydroxyapatite (HA) and Beta Tricalcium Phosphate (βTCP) to achieve a highly regulated resorption rate, mimicking real bone formation. Optimal micro- and macro porosity is achieved through a sophisticated process of synthesis, the use of a high-quality porogen, and controlled sublimation and sintering. The result is a line of highly osteoconductive grafts, ideal for cell colonisation and the free flow of interstitial fluids. The easy to handle OssGro® product range further simulates the formation of new bone through the release of calcium and phosphate ions and is easily able to absorb osteogenic proteins.

Benefiting from the same cutting edge technology used in the production of OssGro®; the X-grip® system includes a screw and optional affix sheath, which can be used to attach an autograft, or eTiss® allograft, tendon to the tibia and femur during ACL reconstruction surgeries.

Leader Biomedical’s new orthobiologics portfolio now includes: OssGro® granules, OssGro® sticks, OssGro® wedges, OssGro® Strip, X-grip® screw, X-grip® sheath, and Ossfinity®. Ossfinity® is a resorbable hydrogel putty with hydroxyapatite (HA) and Beta Tricalcium Phosphate (βTCP), that acts as a carrier for rapid vascularisation and mineralisation. OssGro® Strip is composed of highly purified Type 1 porcine collagen for optimal handling and containment.

To learn more about this new product range, we invite attendees to stop by the AAOS Annual Meeting - Booth #4077 (Hall WB) March 2-4, 2016.

About Leader Biomedical

Leader Biomedical (leaderbiomedical.com) seeks to become the leading provider of biomaterials and medical implant solutions. Our mission is to bring next generation technologies, products and healthcare solutions to global markets, with an emphasis on high-growth markets.

Disclaimer: The OssGro®, eTiss®, and X-grip® are not for sale in the US.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Leader Biomedical

 
 

PREMIUM Article / Social Media:

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Leader Biomedical Launches Comprehensive Orthobiologics Portfolio

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Werner Schoeman - LeaderBiomedical.com 
+31(0)64 640 4968 w.schoeman[.]leaderbiomedical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Leader Biomedical securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Leader Biomedical / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Leader Biomedical Group Enters APAC Market with New Offices in Malaysia
Leader Biomedical Launches Comprehensive Orthobiologics Portfolio
Leader Biomedical Group Partners with BioTiss Austria in New ECOO® Technology Venture
Leader Biomedical Group Establishes Operations in Brazil to Tap the Growing Biomaterials Market
Leader Biomedical Group Receives Approval to Distribute Bioresorbable Grafts in Switzerland
EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership
Leader Biomedical Group Opens Office in India

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)